Health and Fitness Health and Fitness
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
YM BioSciences Prices $70 Million Public Offering of Common Shares
[ Fri, Feb 24th 2012 ] - Market Wire
Perception, Opportunity in Volatility - Research .. is on VIVUS, Inc. and Arena Pharmaceuticals, Inc.
[ Fri, Feb 24th 2012 ] - Market Wire
BIOLASE Announces the Introduction of the Waterla .. Lasers at the Chicago Dental Society Midwinter M
[ Fri, Feb 24th 2012 ] - Market Wire
2012 Economic Outlook - Report Highlights Becton, .. on and Co. and Health Management Associates, Inc.
[ Fri, Feb 24th 2012 ] - Market Wire
Dave Helsel Joins Haemonetics as Vice President of Global Manufacturing
[ Fri, Feb 24th 2012 ] - Market Wire
NxStage Kicks Off Annual Dialysis Conference 2012 .. brity and Former NxStage User Stephen Furst and O
[ Fri, Feb 24th 2012 ] - Market Wire
Titan Medical Inc. Lists on OTCQX Market in the USA
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
[ Fri, Feb 24th 2012 ] - Market Wire
Heska Announces Quarterly Dividend of $0.10 per Share
[ Fri, Feb 24th 2012 ] - Market Wire
HERBORIUM GROUP Announces Signing the Letter of I .. ina Health Resource Inc. for Possible Acquisition
[ Fri, Feb 24th 2012 ] - Market Wire
SANUWAVE Announces Distribution Agreement for Canada
[ Fri, Feb 24th 2012 ] - Market Wire
OncoSec to Present at 10th Annual BioPartnering North America
[ Fri, Feb 24th 2012 ] - Market Wire
Threshold Pharmaceuticals to Present at the Cowen Health Care Conference
[ Fri, Feb 24th 2012 ] - Market Wire
Forest Laboratories Receives European Marketing Approval for Colobreathe Dry Powder Inhaler
Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ] - Market Wire
Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
[ Thu, Feb 23rd 2012 ] - Market Wire
Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Anthera Pharmaceuticals to Present at the Citi Global Health Care Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Avid Bioservices to Present at IBC's Antibody Development and Production Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
National Health Scan Inc. (NHSN) Merger Introduction
[ Thu, Feb 23rd 2012 ] - Market Wire
DURECT to Participate in Upcoming Healthcare Conferences
[ Thu, Feb 23rd 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Citi 2012 Global Health Care Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Medtronic CFO Gary Ellis to Speak at Citi Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Hospira Joins the Generic Pharmaceutical Association
[ Thu, Feb 23rd 2012 ] - Market Wire
Amarantus BioSciences to Present at the 2012 Nati .. ent Banking Association Conference in New Orleans
[ Thu, Feb 23rd 2012 ] - Market Wire
BIOLASE and Cefla Dental Group Announce Exclusive Distribution Agreement
[ Thu, Feb 23rd 2012 ] - Market Wire
SecureAlert, Inc. Reports Record Monitoring Revenues
[ Thu, Feb 23rd 2012 ] - Market Wire
PROLOR Biotech to Present Preclinical Data on Its .. ors VIIa and IX at European Hemophilia Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Theragenics Reports Revenue & Earnings for Fourth Quarter & Year-End 2011
[ Thu, Feb 23rd 2012 ] - Market Wire
MAP Pharmaceuticals Issued Additional U.S. Patent .. id Treatment of Migraine Based Upon Pharmacokinet
[ Thu, Feb 23rd 2012 ] - Market Wire
Nuvo Research provides an update on its Pennsaid franchise
[ Thu, Feb 23rd 2012 ] - Market Wire
Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy
[ Thu, Feb 23rd 2012 ] - Market Wire
Implant Sciences' Quantum Sniffer Explosives and .. Be Exhibited at Security Trade Show in Madrid, Sp
[ Thu, Feb 23rd 2012 ] - Market Wire
00 am ET
[ Thu, Feb 23rd 2012 ] - Market Wire
PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
[ Thu, Feb 23rd 2012 ] - Market Wire
Teleflex Introduces the FloCath Quicka" Female Catheter and Insertion Kit
Wed, February 22, 2012
[ Wed, Feb 22nd 2012 ] - Market Wire
INSERTING and REPLACING Human Genome Sciences to .. scuss Fourth-Quarter and Full-Year 2011 Financial
[ Wed, Feb 22nd 2012 ] - Market Wire
Paladin and Somaxon Announce Filing of New Drug Submission for Silenor(R)
[ Wed, Feb 22nd 2012 ] - Market Wire
Hospira to Present at the Barclays Capital Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Boston Scientific to Participate in 2012 RBC Capital Markets' Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Hologic to Launch Four New Products at the European Congress of Radiology in Vienna
[ Wed, Feb 22nd 2012 ] - Market Wire
AT&T Selected as Carrier to Connect Boston Scient .. vices: Offering Physician and Patient Convenience
[ Wed, Feb 22nd 2012 ] - Market Wire
ATamp;;T Selected as Carrier to Connect Bo .. vices: Offering Physician and Patient Convenience
[ Wed, Feb 22nd 2012 ] - Market Wire
Mettler-Toledo International Inc. Announces Webcast of Presentation at Citi Health Care Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Concentra Selects Allscripts Electronic Health Record for Concentra Medical Centers
[ Wed, Feb 22nd 2012 ] - Market Wire
Critical Outcome Technologies Inc. Selected for Trade Mission to BioPartnering North America
[ Wed, Feb 22nd 2012 ] - Market Wire
AVI BioPharma Regains NASDAQ Compliance
[ Wed, Feb 22nd 2012 ] - Market Wire
Synta Provides Clinical Update and Reports Fourth Quarter and Year End 2011 Financial Results
[ Wed, Feb 22nd 2012 ] - Market Wire
Shire Announces European Approval of Manufacturing Facility for VPRIV (velaglucerase alfa)
[ Wed, Feb 22nd 2012 ] - Market Wire
US Patent Office Rejects All Claims in Second MonoSol Patent
[ Wed, Feb 22nd 2012 ] - Market Wire
SciClone Pharmaceuticals to Present at RBC Capital Markets' Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Marina Biotech Receives Notice of Allowance for U .. s Lipid Based Nucleic Acid Drug Delivery Platform
[ Wed, Feb 22nd 2012 ] - Market Wire
PAREXEL to Address Proven Approaches to Realize S .. lue at Partnerships in Clinical Trials Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
The Ensign Group, Inc. Secures $21.5 Million Loan From RBS Asset Finance, Inc.
[ Wed, Feb 22nd 2012 ] - Market Wire
Centene Corporation Awarded Missouri Managed Care Contract
[ Wed, Feb 22nd 2012 ] - Market Wire
Lexicon Pharmaceuticals Provides Clinical Pipelin .. 11 Fourth Quarter and Full Year Financial Results
[ Wed, Feb 22nd 2012 ] - Market Wire
Inovio Researchers Successfully Demonstrate RNA Drug Delivery via Electroporation
Tue, February 21, 2012
[ Tue, Feb 21st 2012 ] - Market Wire
Natus Medical to Hold 2011 Fourth Quarter Financial Results Conference Call on February 28
[ Tue, Feb 21st 2012 ] - Market Wire
BRILINTA (ticagrelor) Added to American College o .. tions on Antithrombotic Therapy and Prevention of
[ Tue, Feb 21st 2012 ] - Market Wire
Peter A. Marmerstein Appointed President of West Florida Division
[ Tue, Feb 21st 2012 ] - Market Wire
Genomma Lab Internacional Announces Non-binding P .. tige Brands Holdings for $16.60 Per Share in Cash
[ Tue, Feb 21st 2012 ] - Market Wire
Response Genetics Regains NASDAQ Compliance
[ Tue, Feb 21st 2012 ] - Market Wire
Horizon Pharma to Present at the Cowen and Company Health Care Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Cytokinetics Announces Initiation of Phase I Clin .. tions of Omecamtiv Mecarbil in Healthy Volunteers
[ Tue, Feb 21st 2012 ] - Market Wire
AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences
[ Tue, Feb 21st 2012 ] - Market Wire
China Cord Blood Corporation to Report Third Quar .. irst Nine Months of Fiscal 2012 Financial Results
[ Tue, Feb 21st 2012 ] - Market Wire
Repligen Announces FDA Grant of Priority Review for SecreFloa" NDA
[ Tue, Feb 21st 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the 2012 Citi Global Health Care Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Oncolytics Biotech Inc. Enters into Sponsorship A .. for Randomized Phase II Study in Prostate Cancer
[ Tue, Feb 21st 2012 ] - Market Wire
Oral Treprostinil New Drug Application Accepted by FDA for Review
[ Tue, Feb 21st 2012 ] - Market Wire
PDL BioPharma to Present at Upcoming Conferences
[ Tue, Feb 21st 2012 ] - Market Wire
Salix Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Questcor Recognized by Child Neurology Foundation .. tstanding Corporate Responsibility and Leadership
[ Tue, Feb 21st 2012 ] - Market Wire
Capital Senior Living Corporation to Present at R .. al Healthcare Conference on Wednesday, February 2
[ Tue, Feb 21st 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Positive Phas .. ults of TH-302 in Patients With Pancreatic Cancer
[ Tue, Feb 21st 2012 ] - Market Wire
Simcere Pharmaceutical Group to Announce Fourth Q .. 011 Financial Results on Wednesday, March 7, 2012
[ Tue, Feb 21st 2012 ] - Market Wire
GlucAffect Blood Sugar Management Formula From Reliv Earns Patent
[ Tue, Feb 21st 2012 ] - Market Wire
Inovio's Scientific Advisory Board Chairman Elect .. erican Association for the Advancement of Science
Mon, February 20, 2012
[ Mon, Feb 20th 2012 ] - Market Wire
Sirona Dental Systems Validate and Approve Objet .. l Production to Their Worldwide Resellers and Den
[ Mon, Feb 20th 2012 ] - Market Wire
Galapagos announces GSK decision to exercise opti .. r investigational medicines GLPG0778 and GLPG0555
[ Mon, Feb 20th 2012 ] - Market Wire
Immunotec Provides Corporate Update and Year End Financial Results
[ Mon, Feb 20th 2012 ] - Market Wire
Immunotec Announces Proposed Share Consolidation
[ Mon, Feb 20th 2012 ] - Market Wire
Kristi Ann Matus to Head Aetnaas Government Services Organization
[ Mon, Feb 20th 2012 ] - Market Wire
Cubist Pharmaceuticals to Present at February/March Investor Conferences
[ Mon, Feb 20th 2012 ] - Market Wire
Dako Enters Into an Additional Collaboration With .. ion Diagnostic Test (pharmDx(TM)) for an Investig
[ Mon, Feb 20th 2012 ] - Market Wire
Baxter to Present at the Cowen and Company 32nd Annual Healthcare Conference
[ Mon, Feb 20th 2012 ] - Market Wire
Theragenics to Report Fourth Quarter and Year-end 2011 Financial Results Thursday, February 23
[ Mon, Feb 20th 2012 ] - Market Wire
2012 Economic Outlook -- Report Highlights Boston .. ific Corporation and Varian Medical Systems, Inc.
[ Mon, Feb 20th 2012 ] - Market Wire
2012 Economic Outlook -- Report Highlights Hologic, Inc. and Mattel, Inc.
[ Mon, Feb 20th 2012 ] - Market Wire
Anvita Health Integrates Smart Problem List Inside Covisint and AT&T Healthcare Community Online
[ Mon, Feb 20th 2012 ] - Market Wire
Pfizer and GlaxoSmithKline Look to Curb Costs as Generic Competition Cuts Into Revenues
[ Mon, Feb 20th 2012 ] - Market Wire
Pharmaceutical Employees Fearful of Losing Jobs as Patent Cliffs Loom
[ Mon, Feb 20th 2012 ] - Market Wire
WellCare Health Plans Implements MedAssurant's Star Advantagea" Solution
[ Mon, Feb 20th 2012 ] - Market Wire
PAREXEL International to Present at Citi Global Healthcare Conference
Sat, February 18, 2012
[ Sat, Feb 18th 2012 ] - Market Wire
Bull amp;; Lifshitz, LLP Announces Investigation of SeraCare Life Sciences, Inc.
[ Sat, Feb 18th 2012 ] - Market Wire
Bull & Lifshitz, LLP Announces Investigation of SeraCare Life Sciences, Inc.
Fri, February 17, 2012
[ Fri, Feb 17th 2012 ] - Market Wire
Corcept Therapeutics Incorporated Announces FDA A .. istone): First and Only Approved Medication for C
[ Fri, Feb 17th 2012 ] - Market Wire
Gilead maakt gegevens bekend voor Genotype 1 Null .. atitis C patinten ingeschreven in ELECTRON-studie
[ Fri, Feb 17th 2012 ] - Market Wire
3 Reasons to Fall in Love with Soy For American Heart Month
[ Fri, Feb 17th 2012 ] - Market Wire
ProMetic Improves its Short Term Liquidity by $5.0 Million
[ Fri, Feb 17th 2012 ] - Market Wire
Gilead anuncia datos de los pacientes con hepatit .. lo de genotipo 1 inscritos en el estudio ELECTRON
[ Fri, Feb 17th 2012 ] - Market Wire
TheraSphere proporciona esperanza para los pacientes con cncer de hgado de Turqua
[ Fri, Feb 17th 2012 ] - Market Wire
Gilead verffentlicht Daten fr die an der ELECTRON .. is-C-Patienten mit Genotyp 1, die als Nullrespond
[ Fri, Feb 17th 2012 ] - Market Wire
Abbott Announces 40th Consecutive Annual Increase in Quarterly Dividend
[ Fri, Feb 17th 2012 ] - Market Wire
HCA Announces Collaboration with AirStrip Technologies
[ Fri, Feb 17th 2012 ] - Market Wire
Idera Pharmaceuticals Announces Retirement of Dr. .. Wyngaarden as a Member of the Board of Directors
[ Fri, Feb 17th 2012 ] - Market Wire
A Forward Look, the Year Ahead - Featured Researc .. rmaceuticals, Inc. and ISIS Pharmaceuticals, Inc.
[ Fri, Feb 17th 2012 ] - Market Wire
2012 Economic Outlook - Report Highlights MAKO Surgical Corp. and IAC/InterActiveCorp
[ Fri, Feb 17th 2012 ] - Market Wire
Universal Health Services, Inc. to Participate In Two Upcoming Healthcare Conferences
[ Fri, Feb 17th 2012 ] - Market Wire
CytRx Receives Notification of Non-Compliance with NASDAQ Minimum Bid Requirement
[ Fri, Feb 17th 2012 ] - Market Wire
Sunrise to Host Conference Call and Webcast to Di .. urth-Quarter and Full-Year 2011 Financial Results
[ Fri, Feb 17th 2012 ] - Market Wire
CHMP Recommends Approval of BYETTA for Use With Basal Insulin
[ Fri, Feb 17th 2012 ] - Market Wire
Digirad Corporation Reports Fourth Quarter and Full Year 2011 Financial Results
[ Fri, Feb 17th 2012 ] - Market Wire
Gilead Announces Data for Genotype 1 Null Respond .. r Hepatitis C Patients Enrolled in ELECTRON Study
[ Fri, Feb 17th 2012 ] - Market Wire
Angeion Corporation to Report First Quarter Fisca .. 2 Financial Results on Tuesday, February 28, 2012
[ Fri, Feb 17th 2012 ] - Market Wire
Improved Cord Blood Processing Research on BioLife Solutions CryoStor Published in TRANSFUSION
[ Fri, Feb 17th 2012 ] - Market Wire
Threshold Pharmaceuticals Appoints Dr. Tillman Pearce as Chief Medical Officer
Thu, February 16, 2012
[ Thu, Feb 16th 2012 ] - Market Wire
The Law Firm of Levi &;; Korsinsky Noti .. n Their Investment in TranS1 Inc. of Class Action
[ Thu, Feb 16th 2012 ] - Market Wire
CML Healthcare Inc. Declares February Dividend
[ Thu, Feb 16th 2012 ] - Market Wire
Inergetics Announces the Launch of Its Athlete Endorsement Program
[ Thu, Feb 16th 2012 ] - Market Wire
HealthSouth to Present at the 2012 RBC Capital Markets' Global Healthcare Conference
[ Thu, Feb 16th 2012 ] - Market Wire
DiaMedica Named One of TSX Venture's Top 50 Companies
[ Thu, Feb 16th 2012 ] - Market Wire
Varian Medical Systems to Equip New Proton Treatment Center in Russia
[ Thu, Feb 16th 2012 ] - Market Wire
Xenogenics Received Rights to Polyanhydride Compounds Drug Delivery Patent
[ Thu, Feb 16th 2012 ] - Market Wire
Cubist Pharmaceuticals Appoints Alison Lawton to Board of Directors
[ Thu, Feb 16th 2012 ] - Market Wire
Pivotal Data Demonstrating Efficacy of Plenadren .. ease Tablet) in Adrenal Insufficiency Published i
[ Thu, Feb 16th 2012 ] - Market Wire
Paladin Reports Sixteenth Consecutive Year of Record Revenues
[ Thu, Feb 16th 2012 ] - Market Wire
Bioline Introduces New SensiFASTa" HRM Kit for Gene Mutations and SNP Analysis
[ Thu, Feb 16th 2012 ] - Market Wire
BioSante Exchanges $4 Million Aggregate Principal .. nior Notes for 4.5 Million Shares of Common Stock
[ Thu, Feb 16th 2012 ] - Market Wire
BioLineRx to Place $15 Million in Securities with Institutional Investors
[ Thu, Feb 16th 2012 ] - Market Wire
HeartWare International Reports Fourth Quarter 20 .. #59; Full Year 2011 Revenues of $82.8 Million
[ Thu, Feb 16th 2012 ] - Market Wire
Adeona Becomes Synthetic Biologics, Inc.
[ Thu, Feb 16th 2012 ] - Market Wire
Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors
[ Thu, Feb 16th 2012 ] - Market Wire
BioCryst Reports Fourth Quarter and Full Year 2011 Financial Results
[ Thu, Feb 16th 2012 ] - Market Wire
Spectranetics Fourth Quarter Revenue Increases 11% to $32.5 Million
[ Thu, Feb 16th 2012 ] - Market Wire
Astex Pharmaceuticals to Host Annual Analyst and Investor Day on March 27, 2012
[ Thu, Feb 16th 2012 ] - Market Wire
Acorda Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results
[ Thu, Feb 16th 2012 ] - Market Wire
ICON reports fourth quarter 2011 revenue of $243m .. of $0.07. Backlog increases 19%. (NASDAQ:ICLR) (
Wed, February 15, 2012
[ Wed, Feb 15th 2012 ] - Market Wire
Accuray Incorporated to Speak at Citi 2012 Global Health Care Conference
[ Wed, Feb 15th 2012 ] - Market Wire
China Sky One Medical Reiterates CEO Sick Leave a .. ounces Significant Middle Management Resignations
[ Wed, Feb 15th 2012 ] - Market Wire
Conditions of Growth, Economic Analysis - Researc .. denix Pharmaceuticals, Inc. and Dollar Tree, Inc.
[ Wed, Feb 15th 2012 ] - Market Wire
Daxor Announces Receipt of Order Granting Request .. thdraw Petition for Review and Notice of Finality
[ Wed, Feb 15th 2012 ] - Market Wire
Arena Pharmaceuticals and Human Genome Sciences Continue 2012 Upswing
[ Wed, Feb 15th 2012 ] - Market Wire
Merck vormt joint venture met Supera Farma die in .. aceutische producten op de Braziliaanse markt zet
[ Wed, Feb 15th 2012 ] - Market Wire
ARIAD Announces Issuance of Key U.S. Patent on Ponatinib
[ Wed, Feb 15th 2012 ] - Market Wire
Merck consolida joint venture con Supera Farm, pe .. armaceutici innovativi e farmaci generici di marc
[ Wed, Feb 15th 2012 ] - Market Wire
Merck forme une coentreprise avec Supera Farma da .. es produits pharmaceutiques innovants et des gnri
[ Wed, Feb 15th 2012 ] - Market Wire
Titan Medical Inc. Enters Into Exclusive License .. rsity for Novel Single Port Robotic Surgery Syste
[ Wed, Feb 15th 2012 ] - Market Wire
VentriPoint VMS(TM) Heart Analysis System Install .. at the Largest Children's Hospital in Netherlands
[ Wed, Feb 15th 2012 ] - Market Wire
Clinical Study on Skin Lightening With elure(TM) .. osmetic Dermatology Shows Significant Superiority
[ Wed, Feb 15th 2012 ] - Market Wire
Merck Establishes Joint Venture with Supera Farma .. Pharmaceutical Products and Branded Generics in B
[ Wed, Feb 15th 2012 ] - Market Wire
Merck bildet Joint-Venture mit Supera Farma zur V .. er Pharmaprodukte und Markengenerika in Brasilien
[ Wed, Feb 15th 2012 ] - Market Wire
The Broad Institute Joins the Illumina Genome Network
[ Wed, Feb 15th 2012 ] - Market Wire
Biogen Idec adquiere Stromedix
[ Wed, Feb 15th 2012 ] - Market Wire
DaVita Promotes Javier Rodriguez to President
[ Wed, Feb 15th 2012 ] - Market Wire
BioCryst Announces Promising Results from Preclinical Studies of BCX5191 for Hepatitis C
[ Wed, Feb 15th 2012 ] - Market Wire
Herborium Group Targets Indian Skin Care Market
[ Wed, Feb 15th 2012 ] - Market Wire
WuXi PharmaTech Announces Purchase of Ordinary Shares from General Atlantic
[ Wed, Feb 15th 2012 ] - Market Wire
Santarus Announces FDA Acceptance of UCERIS New D .. duction of Remission of Active Ulcerative Colitis
Tue, February 14, 2012
[ Tue, Feb 14th 2012 ] - Market Wire
The Ensign Group Announces Addition of New Director
[ Tue, Feb 14th 2012 ] - Market Wire
ViroPharma to Participate in Two Upcoming Healthcare Investor Conferences
[ Tue, Feb 14th 2012 ] - Market Wire
Natural Alternatives International, Inc. Files Pa .. ngement Claim Against DNP International Co., Inc.
[ Tue, Feb 14th 2012 ] - Market Wire
Unilens Vision Reports Diluted EPS of $0.12 for Second Quarter of FY2012
[ Tue, Feb 14th 2012 ] - Market Wire
Syneron to Present the New GentleMax Pro(R) at the 2012 South Beach Symposium
[ Tue, Feb 14th 2012 ] - Market Wire
Array BioPharma Announces Closing of Public Offer .. Common Stock and Exercise of Overallotment Option
[ Tue, Feb 14th 2012 ] - Market Wire
International Drug & Explosives Detection Company .. orp. Launches Worldwide Retail Marketing Campaign
[ Tue, Feb 14th 2012 ] - Market Wire
Brookdale Senior Living Announces Acquisition and Financing Transactions
[ Tue, Feb 14th 2012 ] - Market Wire
Delcath Receives Regulatory Approval to Commercia .. ize Hepatic CHEMOSAT Delivery System in Australia
[ Tue, Feb 14th 2012 ] - Market Wire
Sirona Biochem Announces Results in Key Study for Biological Inducer
[ Tue, Feb 14th 2012 ] - Market Wire
Critical Outcome Technologies Inc. to Deliver Scientific Podium Presentation on COTI-2
[ Tue, Feb 14th 2012 ] - Market Wire
Perrigo Announces the Launch of Loratadine-D 12 S .. st Store Brand Launch That Compares to Claritin-D
[ Tue, Feb 14th 2012 ] - Market Wire
Dynatronics Announces Second Quarter Results
[ Tue, Feb 14th 2012 ] - Market Wire
BioCorp Ventures and Senesco Enter Into License A .. or the Application of eIF5A to Sustainable Energy
[ Tue, Feb 14th 2012 ] - Market Wire
Trimel Pharmaceuticals' Female Sexual Dysfunction Program Achieves Key Milestones
[ Tue, Feb 14th 2012 ] - Market Wire
Amedisys Issues Heart Health Month Call-to-Action
[ Tue, Feb 14th 2012 ] - Market Wire
STAAR Surgical Previews Strong Visian ICLa" Presence at the Upcoming World Ophthalmology Congress
[ Tue, Feb 14th 2012 ] - Market Wire
AVEO Reports 2011 Financial Results and Highlights Fourth Quarter Progress
[ Tue, Feb 14th 2012 ] - Market Wire
Marina Biotech Announces Closure of Cambridge Sit .. tion of R&;;D Operations in Bothell, WA
[ Tue, Feb 14th 2012 ] - Market Wire
HeartWare Announces Date for FDA Advisory Committee Panel
[ Tue, Feb 14th 2012 ] - Market Wire
Santarus Increases Revolving Line of Credit to $35 Million and Extends Maturity to February 2015
Mon, February 13, 2012
[ Mon, Feb 13th 2012 ] - Market Wire
U.S. FDA Grants Priority Review for Truvada for Reducing the Risk of Acquiring HIV Infection
[ Mon, Feb 13th 2012 ] - Market Wire
Molina Healthcare of Ohio Receives "Commendable" NCQA Status
[ Mon, Feb 13th 2012 ] - Market Wire
Law Offices of Howard G. Smith Announces Investigation of SeraCare Life Sciences, Inc.
[ Mon, Feb 13th 2012 ] - Market Wire
ERT to Present at the Leerink Swann 2012 Global Healthcare Conference February 16, 2012
[ Mon, Feb 13th 2012 ] - Market Wire
Amgen to Present at the Leerink Swann Global Healthcare Conference
[ Mon, Feb 13th 2012 ] - Market Wire
Covance to Present at Leerink Swann 2012 Global Healthcare Conference
[ Mon, Feb 13th 2012 ] - Market Wire
Medisafe 1 Technologies to Start the $1MM Stock R .. ase Program of 10MM Shares up to 10 Cents a Share
[ Mon, Feb 13th 2012 ] - Market Wire
Regeneron Announces Presentation at the Leerink Swann 2012 Global Healthcare Conference
[ Mon, Feb 13th 2012 ] - Market Wire
Alnylam Pharmaceuticals Announces Proposed Public Offering of Common Stock
[ Mon, Feb 13th 2012 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces I .. eaches of Fiduciary Duty by the Board of SeraCare
[ Mon, Feb 13th 2012 ] - Market Wire
ZYTO Announces Plans for 7th Annual Conference
[ Mon, Feb 13th 2012 ] - Market Wire
Bernstein Liebhard LLP Announces That Less Than F .. med Investors to Make a Motion for Lead Plaintiff
[ Mon, Feb 13th 2012 ] - Market Wire
Fresh Start Private Management Inc. Licenses Its .. hol Treatment to Glacier Holdings LLC for Florida
[ Mon, Feb 13th 2012 ] - Market Wire
ChemoCentryx Completes Initial Public Offering
[ Mon, Feb 13th 2012 ] - Market Wire
Law Firm Brower Piven Announces Investigation in .. on of SeraCare Life Sciences, Inc. by Linden Capi
[ Mon, Feb 13th 2012 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Investigation of SeraCare Life Sciences, Inc.
[ Mon, Feb 13th 2012 ] - Market Wire
Moody's Raises Boston Scientific's Credit Rating To Investment Grade
[ Mon, Feb 13th 2012 ] - Market Wire
Insulet Corporation to Present at the Leerink Swann Global Healthcare Conference
[ Mon, Feb 13th 2012 ] - Market Wire
Unilife to Present at the 2012 Leerink Swann Conference in New York City on February 15th
[ Mon, Feb 13th 2012 ] - Market Wire
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeraCare Life Sciences, Inc.
[ Mon, Feb 13th 2012 ] - Market Wire
TPI Begins Construction of Qionglai Facility (QLF)

Endo Pharmaceuticals to Present at J.P. Morgan Annual Global High Yield & Leveraged Finance Conference


//health-fitness.news-articles.net/content/2012/ .. bal-high-yield-leveraged-finance-conference.html
Published in Health and Fitness on Friday, February 17th 2012 at 13:55 GMT by Market Wire   Print publication without navigation


Endo Pharmaceuticals to Present at J.P. Morgan Annual Global High Yield... -- CHADDS FORD, Pa., Feb. 17, 2012 /PRNewswire/ --

Endo Pharmaceuticals to Present at J.P. Morgan Annual Global High Yield & Leveraged Finance Conference

[ ]

CHADDS FORD, Pa., Feb. 17, 2012 /PRNewswire/ -- Endo Pharmaceuticals Holdings (Nasdaq: [ ENDP ]) today announced that Mark Gottlieb, vice president and treasurer, will present a corporate overview at the J.P. Morgan Annual Global High Yield & Leveraged Finance Conference on Wednesday, February 29, 2012 at 10:20 a.m. ET.  The conference will be held at the Loews Hotel in Miami Beach, FL.

A live webcast and audio archive of the presentation will be available on the company's website at [ http://www.endo.com/ ].  Click on Investor Relations, and then the link to the Event and Presentation.  Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Endo

Endo Pharmaceuticals Holdings is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments - branded pharmaceuticals, generics and devices and services. We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals Holdings and its businesses American Medical Systems, HealthTronics and Qualitest Pharmaceuticals, please visit [ http://www.endo.com/ ].

SOURCE Endo Pharmaceuticals Holdings

[ Back to top ]

RELATED LINKS
[ http://www.endo.com ]


Publication Contributing Sources